Also known as hunan fangsheng pharmaceutical
Hunan Fangsheng Pharmaceutical is a Changsha, China company founded in 2002 and listed on the Shanghai Stock Exchange since December 2014 under code 603998. It describes itself as a health industry group combining pharmaceutical manufacturing, health products, and medical services, centered on innovative traditional Chinese medicine products. It operates six production bases across China and has more than 20 subsidiaries, including entities in generic drugs, gene drug engineering research, an oncology hospital, and elderly care. Its listed business areas include pharmaceuticals, health products, industrial hemp, medical services, research services, and clinical trial services. It is classified here as a corporate investor with about $433 million in assets.
Browse more corporate investors and other institutional investors by location and type in the LPbacked limited-partner database.
Hunan Fangsheng Pharmaceutical is a corporate investor based in Changsha, China, managing approximately $433M in assets.
Hunan Fangsheng Pharmaceutical is headquartered in Changsha, China.
Hunan Fangsheng Pharmaceutical manages approximately $433M in assets under management.
Hunan Fangsheng Pharmaceutical was founded in 2002.
Hunan Fangsheng Pharmaceutical focuses on Early Stage, Early Stage: Seed, Early Stage: Start-up, Expansion / Late Stage, Venture (General), Healthcare.
Verified contact details, key decision-makers, and investment preferences for Hunan Fangsheng Pharmaceutical are available on LPbacked. Create a free account to access them.